Bleomycin therapy in advanced hodgkin's disease and epidermoid cancers.
D000230:Adenocarcinoma / Q000188:drug therapy; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008171:Lung Diseases / Q000209:etiology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy; D013724:Teratoma / Q000188:drug therapy; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy; D014625:Vaginal Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; D008727:Methotrexate